US FDA expands approval for J&J's drug for rare blood disorder

The U.S. ​Food and ‌Drug Administration ​has ​approved the expanded ⁠use ​of ​Johnson & Johnson's drug to ​treat ​a rare blood ‌disorder, ⁠the company said ​on ​Monday.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。